Borean Pharma receives Notice of Allowance of HIV drug patent by U.S. Patent & Trademark Office
25-Oct-2007 -
Borean Pharma, ApS announced that it has received a Notice of Allowance from the U.S. Patent & Trademark Office (USPTO) in connection with Borean's patent application for Human Immunodeficiency Virus (HIV) fusion inhibitors for treating AIDS. The USPTO has stated that it intends to grant patent ...
AIDS
fusion proteins
immunodeficiency
+3